Rank 16 • AI & Clinical Intelligence
PathAI
Applies machine learning and artificial intelligence to improve pathology diagnostic accuracy and accelerate oncology drug development.
Visit website- Signal Score
- 91.9
- Total raised
- $250M
- Stage
- Series C
- Founded
- 2016
- Headquarters
- Boston, United States
- Region
- North America
Their signal
By partnering with major biopharma players, PathAI transforms pathology from subjective qualitative assessment to highly reproducible, AI-quantified clinical insights.
Signal Score 91.9editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.